Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. News
  7. Summary
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 08/03 03:38:29 pm
175.325 EUR   +0.33%
08/02MARKETMIND : A new sunny day, with the same old clouds
RE
07/30DGAP-PVR : Merck KGaA: Release according to -4-
DJ
07/30DGAP-PVR : Merck KGaA: Release according to -3-
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck : TeamViewer acquires U.S. augmented reality software firm Upskill

03/02/2021 | 03:20am EDT
FILE PHOTO: First day of trading of TeamViewer AG in Frankfurt

BERLIN (Reuters) - German remote connectivity software company TeamViewer said on Tuesday it had acquired Upskill, a U.S. company that specialises in augmented reality applications for front-line workers.

The deal marks the third takeover by CEO Oliver Steil since TeamViewer, headquartered in Goeppingen, was floated in Sept. 2019 by private equity backer Permira. Terms were not disclosed for the transaction.

Steil said in an interview that the Upskill takeover would strengthen TeamViewer's presence in the United States, its largest market by billings. He was still in the market for deals that would widen its range of products.

"We are interested in complementary teams with complementary capabilities," Steil said. TeamViewer recently raised a 300 million euro ($360 million) loan, has cash on hand and strong cash flow that can be put to work, he added.

Steil had flagged his interest in expanding into augmented reality and smart devices when TeamViewer reported annual results last month, and forecast that its business would grow by around a third this year.

With the acquisition of Upskill, TeamViewer acquires the ability to support workers using smart glasses and handheld devices to inspect factory equipment, as well as a client list that includes Boeing and Merck KGaA.

"Our existing customers will benefit from an accelerated product development roadmap, global reach, and additional solutions and features within the TeamViewer portfolio," said Upskill CEO Brian Ballard.

Upskill, founded in 2010, is privately held and has raised a total of $53 million in venture backing according to Crunchbase. ($1 = 0.8324 euros)

(Reporting by Douglas Busvine; Editing by Caroline Copley and Louise Heavens)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
MERCK KGAA -0.09% 174.6 Delayed Quote.24.51%
TEAMVIEWER AG -10.11% 25.61 Delayed Quote.-35.00%
All news about MERCK KGAA
08/02MARKETMIND : A new sunny day, with the same old clouds
RE
07/30DGAP-PVR : Merck KGaA: Release according to -4-
DJ
07/30DGAP-PVR : Merck KGaA: Release according to -3-
DJ
07/30DGAP-PVR : Merck KGaA: Release according to -2-
DJ
07/30DGAP-PVR : Merck KGaA: Release according to Article 40, Section 1 of the WpHG [t..
DJ
07/30MARKETMIND : Ready for a summer lull?
RE
07/28MERCK KGAA : Goldman Sachs keeps a Sell rating
MD
07/28MARKETMIND : Gearing up for Jay
RE
07/27MERCK KGAA : JP Morgan remains its Buy rating
MD
07/27DGAP-PVR : Merck KGaA: Release according to -4-
DJ
More news
Financials
Sales 2021 18 942 M 22 471 M 22 471 M
Net income 2021 2 561 M 3 038 M 3 038 M
Net Debt 2021 8 913 M 10 573 M 10 573 M
P/E ratio 2021 29,2x
Yield 2021 0,86%
Capitalization 75 977 M 90 074 M 90 132 M
EV / Sales 2021 4,48x
EV / Sales 2022 4,16x
Nbr of Employees 57 850
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | MarketScreener
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 174,75 €
Average target price 154,55 €
Spread / Average Target -11,6%
EPS Revisions
Managers and Directors
BelÚn Garijo Lˇpez Chairman-Executive Board & CEO
Marcus Kuhnert Chief Financial Officer
Wolfgang Heinz BŘchele Chairman-Supervisory Board
Maria Rivas Chief Medical Officer & Senior Vice President
Laura Matz Chief Science & Technology Officer
Sector and Competitors